Lowell Thomas Holden, CFO at Nascent Biotech Inc. (NBIO), sold 5,000 shares at $0.26 ($1K) on 2022-07-21, disclosed to the SEC on 2022-07-25.
Open-market sale of $1k NBIO by CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| NBIO | BUY | 2023-02-02 | $3K | — | Filing → |
| SKKY | BUY | 2022-04-11 | $2K | — | Filing → |
| NBIO | BUY | 2020-01-06 | $850 | — | Filing → |